Hybrid Neuroprosthetic and Neurorobotic Devices for Functional Compensation and Rehabilitation of Motor Disorders
The HYPER project focuses its activities on new wearable neurorobotic (NR) and motor neuroprosthetic (MNP) combined with virtual reality (VR) systems to overcome the major limitations of current rehabilitation solutions for the particular case of Cerebrovascular Accident (CVA), Cerebral Palsy (CP) and Spinal Cord Injury (SCI).
It is a combination of biological and integrated artificial structures to restore motor function in SCI patients through functional compensation and to promote motor control re-learning in patients suffering from CVA and CP.
The improvement of physical rehabilitation therapies depends on achieving a more interrelated and transparent communication between the human system and the machines, and therefore, different levels of human neural activity are explored.
The project will both functionally and clinically validate the concept of developing hybrid NR-MNP-VR systems for rehabilitation and functional compensation of motor disorders, under the assist-as-needed paradigm. The main challenges will be the improvement of the therapy outcome and the earlier regaining of the function.
In addition, HYPER proposes a multimodal BCI. Its main goal is to explore different levels of neural activity, characterise the required support and the user involvement, and modify the intervention at the periphery with hybrid NR-NP-VR systems.
Vicomtech is coordinating the working group RT6 which is focused on the adaptation of MNPs, NRs and VR to the users and the application scenarios. The workload will include different tasks such as: definition of user groups and user requirements, evaluation of scales and standards, and definition of evaluation procedures, clinical tests and user assessment of application of VR and 3D virtual world technologies in the rehabilitation of neuromotor disorders validation protocols. Several technologies will be applied at the common rehabilitation protocol in order to increase the final outcome and reduce the duration of the therapy.